semaglutide colombia oral Oral Semaglutide Gets FDA Approval for CV Event Reduction in High-risk Diabetes Patients Semaglutide & GLP1 & Weight

Observe patients carefully for signs and symptoms of acute pancreatitis, which may include persistent or severe abdominal pain (sometimes radiating to the back), with or without nausea or vomiting

Symptoms of hypoglycemia include dizziness, sweating, confusion, and fainting

Semaglutide mimics this hormone at therapeutic levels helping you feel fuller longer and reducing cravings between meals

Patients may also experience some mild side effects, such as nausea, gastrointestinal symptoms like diarrhea or constipation, and headaches

In clinical trials, some participants reported no discernible side effects during the entire first month at the 0.25 mg starting dose